https://www.selleckchem.com/products/ABT-263.html
Although plitidepsin is administered intravenously and its toxicity profile remains to be fully characterized, this compound may be a promising alternative COVID-19 therapeutic.Current guidelines recommend against systematic screening or treating asymptomatic bacteriuria (A among kidney transplant (KT) recipients, although the evidence regarding episodes occurring early after transplantation or in the presence of anatomical abnormalities is inconclusive. Oral fosfomycin may constitute a good option for the treatment of post-transplant
Like
Comment
Share
